Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0WOBTH
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DS-3939a
|
|||||
| Synonyms |
Anti TA-MUC1 antibody drug conjugate; Anti TA-MUC1 antibody drug conjugate (Daiichi Sankyo Company); DS-3939; DS-3939a; PankoMab GEX
Click to Show/Hide
|
|||||
| Organization |
Daiichi Sankyo Co., Ltd.; Glycotope GmbH
|
|||||
| Drug Status |
Phase 1/2
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
7.9
|
|||||
| Antibody Name |
Gatipotuzumab
|
Antibody Info | ||||
| Antigen Name |
Mucin-1 (MUC1)
|
Antigen Info | ||||
| Payload Name |
DX-8951 derivative (DXd)
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Mc-Gly-Gly-Phe-Gly
|
Linker Info | ||||
| Conjugate Type |
Random Cysteines
|
|||||
| Combination Type |
deruxtecan
|
|||||
